Application processes at NIH are changing. Applicant organizations are encouraged to start preparing for this transtion by registering with Grants.gov and NIH eRA Commons now. |
Muscular Dystrophy: Pathogenesis and Therapies (R21)
Release Date: August 3, 2006
Announcement Number: PA-06-508
Application Receipt Date:
October 1, 2006
February 16, 2007
June 16, 2007
October 16, 2007
Funding Contact: John Porter, Ph.D.
Program Area: Channels, Synapses and Neural Circuits
Also See:
http://grants.nih.gov/grants/guide/pa-files/PA-05-038.html
Brief Description:
The National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), the National Institute of Neurological
Disorders and Stroke (NINDS), the National Institute of Child Health and Human Development (NICHD) and the National Heart,
Lung, and Blood Institute (NHLBI) encourage investigator-initiated research grant applications for projects studying pathogenesis
and therapies for the muscular dystrophies. Responses to this announcement may include basic, translational or patient-oriented
studies of Duchenne/Becker muscular dystrophy, facioscapulohumeral dystrophy, myotonic dystrophy or other forms of muscular
dystrophy.
Choose an option to view additional funding announcements |
New Announcements | Research Area | RFAs Only | PAs Only | RFPs Only | Notices Only | Supplements Only | All Announcements | Archives |